Võrdle meetodeid

	Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)	Neuropaatilise valu sümptomite inventuur (NPSI)
Valdkond	Neuroloogia	Neuroloogia
Perekond	Process / pipeline	Process / pipeline
Tekkeaasta	2001	2004
Looja	Mark I. Bennett, University of Leeds	Didier Bouhassira, INSERM, France
Tüüp	Hybrid questionnaire and clinician examination	Self-report questionnaire
Algallikas	Bennett, M. I. (2001). The LANSS Pain Scale: The Leeds Assessment of Neuropathic Symptoms and Signs. Pain, 92(1-2), 147-157.	Bouhassira, D., Attal, N., Fermanian, J., Alchaar, H., Gautron, M., Masquet, B., Rostaing, S., Lanteri-Minet, M., Collin, E., Grisart, J., & Boureau, F. (2004). Development and validation of the Neuropathic Pain Symptom Inventory. Pain, 108(3), 248-257.
Rööpnimetused	LANSS Pain Scale, Leeds Neuropathic Symptoms	Neuropathic Pain Symptom Inventory, NPSI Scale
Seotud	4	3
Kokkuvõte	The LANSS is a brief seven-item hybrid screening and diagnostic tool designed to differentiate neuropathic pain from non-neuropathic (nociceptive) pain. Developed by Mark Bennett at the University of Leeds in 2001, it combines five patient-reported symptom items with two clinician-performed neurological examination findings. With a sensitivity of 82% and specificity of 80%, LANSS is among the most accurate tools for identifying whether a patient's pain has a neuropathic component, making it invaluable in clinical practice and research settings where pain etiology classification is essential.	The NPSI is a 12-item self-report questionnaire specifically designed to assess and quantify the diverse symptoms characteristic of neuropathic pain. Developed by Bouhassira and colleagues in 2004, it evaluates five distinct symptom dimensions: burning pain, pressing pain, paroxysmal pain, evoked pain, and paresthesias. The NPSI is widely used in research and clinical practice to characterize neuropathic pain profiles, quantify symptom severity, and track treatment response.